The University of Oklahoma has been recognized by the Fulbright Program for its academic excellence and impactful contributions to international education and research, with its Health Campus earning the university recognition as a “Top Producer” of Fulbright U.S. Scholars. The OU Health Campus tied for the most Scholars nationally among institutions in the “Special Focus: Technology, Engineering & Sciences, Medical & Health” category.
University of Oklahoma researchers have created a new drug delivery system that helps cancer cells take in much more of a treatment, improving its ability to kill tumors. The findings are published in Science Advances.
The University of Oklahoma College of Medicine has announced the appointment of T.R. Lewis, M.D., as associate dean for student affairs, effective Jan. 25, 2026, pending approval by the OU Board of Regents.
The University of Oklahoma College of Medicine has named Kelly Stratton, M.D., FACS, as associate dean for veterans affairs, pending approval by the OU Board of Regents.
A newly approved National Cancer Institute-funded clinical trial aims to improve survival for head and neck cancer patients whose disease returns after radiation therapy – a setback that affects up to 40% of patients and is often associated with poor outcomes.